Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Galderma
Deal Size : Undisclosed
Deal Type : Acquisition
Galderma Successfully Completes Acquisition of ALASTIN Skincare
Details : ALASTIN’s synergistic portfolio in skincare will increase Galderma’s ability to serve the needs by the patented TriHex Technology®, a blend of peptides (Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1) and active botanicals to support the appearance o...
Brand Name : Alastin Skincare
Molecule Type : Peptide
Upfront Cash : Undisclosed
January 05, 2022
Lead Product(s) : Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Galderma
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Galderma
Deal Size : Undisclosed
Deal Type : Acquisition
Details : ALASTIN’s product offerings are backed by the patented TriHex Technology®, a proprietary blend of peptides and active botanicals to support the appearance of rejuvenated skin, which will now be apart of Galderma.
Brand Name : Alastin Skincare
Molecule Type : Peptide
Upfront Cash : Undisclosed
November 29, 2021
Lead Product(s) : Palmitoyl Tripeptide-1,Myristoyl Tripeptide-1,Herbal Extract
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Galderma
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?